ASH-EHA Translational Research Training in Hematology
The 2019 application cycle is now open
. The letter of intent submission deadline is June 25, 2019.
A joint effort of the American Society of Hematology (ASH) and the European Hematology Association (EHA), Translational Research Training in Hematology (TRTH) is a unique, year-long training and mentoring program focused on helping junior researchers build successful careers in hematologic translational research.
Each year, 20 early-career scientists (10 from North America and 10 from Europe) are selected to participate in the rigorous training program led by faculty who are international leaders in hematology. Topics covered include biostatistics and biomarkers, genetics and molecular biology, ethics, and phase I clinical study design.
|Letter of Intent Deadline||June 25, 2019|
|Notification of Awards||Early December 2019|
|Spring Course in France||March 20-27, 2020|
ASH receives support for TRTH from: Astellas Pharma, Bristol-Myers Squibb, Gilead Sciences, Inc., and Takeda Oncology.
For information about supporting the award, visit ASH's Corporate Support page or contact firstname.lastname@example.org.
For more information, please contact the EHA Executive Office at email@example.com.
Never miss an important deadline—sign up to receive email updates about ASH awards and training programs.
Get email updates
back to top